PB2060: THE MDS-SPECIFIC COMORBIDITY INDEX (MDS-CI) PREDICTS SURVIVAL INDEPENDENTLY FROM DIPSS AND MIPSS70 IN PATIENTS WITH OVERT MYELOFIBROSIS NOT ELIGIBLE FOR ALLOGENEIC STEM CEL...

por Koster, K.-L., Messerich, N.-M., Volken, T., Cogliatti, S., Lehmann, T., Holbro, A., Benz, R., Graf, L., Demmer, I., Jochum, W., Silzle, T.
Publicado 2022